Houlihan Lokey Advises Vitruvian Partners

Houlihan Lokey is pleased to announce that Vitruvian Partners LLP (Vitruvian) acquired Fotona Holdings (Netherlands) BV (Fotona) from European-Asian private equity firm AGIC Capital (AGIC). AGIC reinvested alongside Vitruvian and continues to support Fotona and its management team with the company’s international growth plans. The transaction closed on 14 October 2021.

Established in 1964, Fotona is a leading medical-laser-focused, energy-based devices (EBDs) company. It develops, manufactures, and distributes market-leading medical laser systems and other EBDs with product lines covering aesthetics, dental, and gynaecology applications. Fotona currently serves a global customer base through a direct sales force in the US and China complemented by distributors covering over 65 countries worldwide.

Vitruvian is an international private equity firm that specializes in growth capital and growth buyout investments globally. The firm was established in 2007 and has c. €10.0 billion of assets under management. It is headquartered in London, with other global offices in Munich, Stockholm, Luxembourg, San Francisco, and Shanghai.

Houlihan Lokey served as both the M&A and financing advisor on the transaction. This deal highlights Houlihan Lokey’s leading global healthcare and medical technology focus, coupled with the firm’s debt capital markets expertise in complex, cross-border transactions. It also represents a landmark deal for the European Healthcare team.

RELATED: Healthcare, Capital Markets